Literature DB >> 12579968

[Effects of leflunomide on immunological liver injury].

H W Yao1, Y Jin, J Li, Y F Zhang, C Y Li, S Y Xu.   

Abstract

AIM: To study the effect of leflunomide (Lef) on immunological liver injury in mice.
METHODS: Immunological liver injury was induced by tail vein injection of BCG + LPS (BCG 2.5 mg, 1 d, LPS 10 micrograms, 10 d). The ALT, AST, NO level in plasma and MDA, GSHpx in liver homogenate were assayed by spectroscopy. The serum content of TNF-alpha was determined by ELISA. IL-1, IL-2 and ConA-induced splenocyte proliferation response were determined by methods of 3H-infiltrated cell proliferation.
RESULTS: Immunological liver injury induced by BCG + LPS was successfully duplicated. Lef (4, 12, 36 mg.kg-1) was found to significantly decrease the serum transaminase (ALT, AST) activity and MDA content in liver homogenate, and improved reduced GSHpx level of liver homogenate. Furthermore, Lef (4, 12, 36 mg.kg-1) significantly reduced TNF-alpha and NO level in serum, and IL-1 production by PM psi. Moreover, the decreased IL-2 production and ConA-induced splenocyte proliferation response were further inhibited.
CONCLUSION: Lef showed significant protective action on immunological liver injury in mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12579968

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  2 in total

1.  A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells.

Authors:  Hong Wei Yao; Jun Li; Ji Qiang Chen; Shu Yun Xu
Journal:  Inflammation       Date:  2004-04       Impact factor: 4.092

2.  Leflunomide attenuates hepatocyte injury by inhibiting Kupffer cells.

Authors:  Hong-Wei Yao; Jun Li; Ji-Qiang Chen; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.